UnitedHealth Group Incorporated (NYSE:UNH) Position Reduced by Clarity Wealth Advisors LLC

Clarity Wealth Advisors LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 556 shares of the healthcare conglomerate’s stock after selling 25 shares during the quarter. Clarity Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $281,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in UNH. AMF Tjanstepension AB raised its holdings in shares of UnitedHealth Group by 88.0% during the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock valued at $151,374,000 after purchasing an additional 121,180 shares in the last quarter. Hudson Value Partners LLC lifted its position in shares of UnitedHealth Group by 8.3% in the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after buying an additional 82 shares during the last quarter. Wealth Group Ltd. raised its stake in shares of UnitedHealth Group by 4.0% in the 3rd quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock valued at $1,039,000 after acquiring an additional 68 shares in the last quarter. Sendero Wealth Management LLC grew its holdings in UnitedHealth Group by 1.4% during the third quarter. Sendero Wealth Management LLC now owns 2,692 shares of the healthcare conglomerate’s stock valued at $1,574,000 after purchasing an additional 37 shares during the last quarter. Finally, Tobam lifted its stake in shares of UnitedHealth Group by 22.7% in the third quarter. Tobam now owns 2,320 shares of the healthcare conglomerate’s stock worth $1,356,000 after buying an additional 429 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on UNH shares. KeyCorp restated an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Oppenheimer upped their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. TD Cowen increased their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Finally, Royal Bank of Canada cut their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Buy” and an average target price of $629.32.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Down 0.6 %

Shares of NYSE UNH opened at $526.68 on Friday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The firm’s 50-day simple moving average is $530.85 and its 200 day simple moving average is $564.52. The company has a market cap of $484.69 billion, a price-to-earnings ratio of 33.98, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period last year, the company earned $5.83 EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.